蛋白质自组装构筑酶驱动纳米马达用于光动力抗肿瘤研究
结题报告
批准号:
22001054
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
孙鸿程
依托单位:
学科分类:
超分子化学
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
孙鸿程
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
纳米药物递送系统的设计对提高抗肿瘤药物治疗效果至关重要。项目提出利用可逆共价自组装策略发展智能蛋白质纳米结构的新概念,通过构筑酶催化驱动的蛋白质纳米马达主动给药系统,提高药物递送效率和肿瘤治疗效果。本项目以铁蛋白、斑驳病毒蛋白和SP1蛋白为基元,通过自组装构筑具有氧化还原响应的双硫、双硒或双碲桥连纳米笼或封端纳米管,实现药物负载和肿瘤内可控释放。通过化学或生物法共价修饰驱动酶(过氧化氢酶CAT、葡萄糖氧化酶GOx)构建酶催化驱动的智能马达,并调节了马达主动靶向运输药物和肿瘤部位渗透滞留能力。以二氢卟吩e6(Ce6)和阿托伐醌(ATO)为药物模型进行肿瘤光动力学治疗(PDT)研究,利用马达产氧和抑制线粒体氧消耗协同改善肿瘤乏氧微环境,增强PDT抗肿瘤疗效。通过结合蛋白质组装、自驱动马达和PDT抗肿瘤的概念,为基于蛋白质纳米结构的智能纳米药物递送系统设计与研究提供理论指导和奠定技术基础。
英文摘要
The design of nano-drug delivery system is great essential for improving the therapeutic efficacy of antineoplastic drugs. A new concept for developing intelligent protein nanostructures via reversible covalent self-assembly strategy was proposed in this project, to construct enzyme-propelled protein nanomotors for active-drug delivery systems, which improving the drug delivery efficiency and enhancing tumor therapy. We construct redox-responsive disulfide-, diselenide- or ditelluride-containing nanocages or terminated nanotubes for drug loading and controlled release in tumor, through self-assembly of apoferritin (aFt), mottle virus (CCMV) or SP1 building blocks. Serious of enzyme-propelled protein nanomotors are further constructed by chemically or biologically modification with catalase (CAT) and glucose oxidase (GOx), which improving the ability of active-targeting drug transhipment and enhancing deep penetration and retention in tumor. Taking photosensitizer chlorin e6 (Ce6) and atovaquone (ATO) as antitumor drugs for photodynamic therapy (PDT), the tumor hypoxia could be cooperatively reversed by the oxygen (O2) production and inhibition of mitochondrial O2 consumption, which further improving antitumor therapeutic efficacy. Through combining the concepts of protein self-assembly, self-propelled nanomotor and photodynamic tumor therapy, the implementation of this project will provide theoretical guidance and technical basis for the design and study of intelligent nano-drug delivery systems based on protein superstructures.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.cej.2022.136620
发表时间:2022
期刊:Chemical Engineering Journal
影响因子:15.1
作者:Jieqiong Wang;Fei Li;Zhengwei Xu;Mingsong Zang;Shengda Liu;Tianhe Li;Jiayun Xu;Hongcheng Sun;Shuangjiang Yu;Junqiu Liu
通讯作者:Junqiu Liu
DOI:10.1007/s12274-023-5503-7
发表时间:2023-04
期刊:Nano Research
影响因子:9.9
作者:Mingsong Zang;Yuancheng Ji;Xiaoran Ding;Zhengwei Xu;Jinxing Hou;Jianxin Sun;Jiayun Xu;Shuangjiang Yu;Hongcheng Sun;Tingting Wang;Junqiu Liu
通讯作者:Mingsong Zang;Yuancheng Ji;Xiaoran Ding;Zhengwei Xu;Jinxing Hou;Jianxin Sun;Jiayun Xu;Shuangjiang Yu;Hongcheng Sun;Tingting Wang;Junqiu Liu
DOI:10.3389/fbioe.2023.1277107
发表时间:2023
期刊:Frontiers in Bioengineering and Biotechnology
影响因子:5.7
作者:Hongcheng Sun;Syed Mazhar Shah;Yuan Gao
通讯作者:Yuan Gao
DOI:10.1002/advs.202301919
发表时间:2023-08
期刊:Advanced science (Weinheim, Baden-Wurttemberg, Germany)
影响因子:--
作者:
通讯作者:
DOI:10.1016/j.cej.2021.132592
发表时间:2022-02
期刊:Chemical Engineering Journal
影响因子:15.1
作者:Shengda Liu;S. Qiao;T. Yan;Xiumei Li;Shuangjiang Yu;Hongcheng Sun;Jiayun Xu;Junqiu Liu
通讯作者:Shengda Liu;S. Qiao;T. Yan;Xiumei Li;Shuangjiang Yu;Hongcheng Sun;Jiayun Xu;Junqiu Liu
基于工程化蛋白质胶囊的酶驱动纳米马达用于增强癌症联合治疗
  • 批准号:
    LY23E030001
  • 项目类别:
    省市级项目
  • 资助金额:
    0.0万元
  • 批准年份:
    2023
  • 负责人:
    孙鸿程
  • 依托单位:
自组装策略构筑酶驱动活体微马达用于肿瘤精准治疗
  • 批准号:
    22371062
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    孙鸿程
  • 依托单位:
国内基金
海外基金